O'Connell RL - Search Results

1

Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study.

Hankey GJ, Anderson NE, Ting RD, Veillard AS, Romo M, Wosik M, Sullivan DR, O'Connell RL, Hunt D, Keech AC. Hankey GJ, et al. J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):281-7. doi: 10.1136/jnnp-2012-303365. Epub 2012 Oct 20. J Neurol Neurosurg Psychiatry. 2013. PMID: 23085934

2

Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study.

Ting RD, Keech AC, Drury PL, Donoghoe MW, Hedley J, Jenkins AJ, Davis TM, Lehto S, Celermajer D, Simes RJ, Rajamani K, Stanton K; FIELD Study Investigators. Ting RD, et al. Diabetes Care. 2012 Feb;35(2):218-25. doi: 10.2337/dc11-1109. Epub 2011 Dec 30. Diabetes Care. 2012. PMID: 22210576 Free PMC article. Clinical Trial.

3

Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Chan KH, O'Connell RL, Sullivan DR, Hoffmann LS, Rajamani K, Whiting M, Donoghoe MW, Vanhala M, Hamer A, Yu B, Stocker R, Ng MK, Keech AC; FIELD Study Investigators. Chan KH, et al. Diabetologia. 2013 Apr;56(4):724-36. doi: 10.1007/s00125-012-2818-4. Epub 2013 Jan 17. Diabetologia. 2013. PMID: 23322233

4

A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials.

Simes J, Voysey M, O'Connell R, Glasziou P, Best JD, Scott R, Pardy C, Byth K, Sullivan DR, Ehnholm C, Keech A; FIELD Study Investigators. Simes J, et al. PLoS One. 2010 Jan 8;5(1):e8580. doi: 10.1371/journal.pone.0008580. PLoS One. 2010. PMID: 20072614 Free PMC article.

5

Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.

Ong KL, Rye KA, O'Connell R, Jenkins AJ, Brown C, Xu A, Sullivan DR, Barter PJ, Keech AC; FIELD study investigators. Ong KL, et al. J Clin Endocrinol Metab. 2012 Dec;97(12):4701-8. doi: 10.1210/jc.2012-2267. Epub 2012 Nov 8. J Clin Endocrinol Metab. 2012. PMID: 23144467 Clinical Trial.

6

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.

Ong KL, Januszewski AS, O'Connell R, Jenkins AJ, Xu A, Sullivan DR, Barter PJ, Hung WT, Scott RS, Taskinen MR, Keech AC, Rye KA. Ong KL, et al. Diabetologia. 2015 Mar;58(3):464-73. doi: 10.1007/s00125-014-3458-7. Epub 2014 Nov 26. Diabetologia. 2015. PMID: 25425220 Clinical Trial.

7

Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study.

Cao JY, Waldman B, O'Connell R, Sullivan DR, Scott RS, Aryal N, Gebski V, Marschner I, Taskinen MR, Simes JR, McGill N, Jenkins AJ, Keech AC; FIELD investigators. Cao JY, et al. Diabetes Obes Metab. 2020 Aug;22(8):1388-1396. doi: 10.1111/dom.14046. Epub 2020 Apr 22. Diabetes Obes Metab. 2020. PMID: 32243036 Clinical Trial.

8

The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study.

Ong KL, Wu L, Januszewski AS, O'Connell R, Xu A, Scott RS, Sullivan DR, Rye KA, Li H, Ma RC, Li L, Gebski V, Jenkins AJ, Jia W, Keech AC. Ong KL, et al. Diab Vasc Dis Res. 2021 Jul-Aug;18(4):14791641211032547. doi: 10.1177/14791641211032547. Diab Vasc Dis Res. 2021. PMID: 34275349 Free PMC article. Clinical Trial.

9

Making sense of trial results: outcomes and estimation.

O'Connell RL, Gebski VJ, Keech AC. O'Connell RL, et al. Med J Aust. 2004 Feb 2;180(3):128-30. doi: 10.5694/j.1326-5377.2004.tb05836.x. Med J Aust. 2004. PMID: 14748677 No abstract available.

10

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes.

Januszewski AS, Chen D, Scott RS, O'Connell RL, Aryal NR, Sullivan DR, Watts GF, Taskinen MR, Barter PJ, Best JD, Simes RJ, Keech AC, Jenkins AJ. Januszewski AS, et al. Sci Rep. 2021 Sep 21;11(1):18708. doi: 10.1038/s41598-021-98064-y. Sci Rep. 2021. PMID: 34548531 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page